The gut microbiome accumulates bacterial diversity over the first several years of life, and plays a critical role in immune development including immune tolerance via production of microbial-derived metabolites such as short chain and polyunsaturated fatty acids. We and others have demonstrated that children who develop allergic sensitization or asthma, exhibit consistent bacterial genera depletions and metabolic perturbations in infancy. Relative to those at low-risk of disease development, the associated products of the perturbed, early life high-risk gut microbiome induce expansion and activity of T-helper 2 cells and reduce the frequency of regulatory T cells in vitro. Thus, the implication is that the very early-life gut microbiome, via microbial-derived metabolites, shapes nascent immune function in a manner consistent with disease or health in childhood. Our most recent studies indicate that the meconium microbiome of high-risk for asthma infants (with at least one asthmatic parent) is distinct from that of low-risk neonates, and exhibits a significantly delayed bacterial diversification trajectory over the first year of life, implicating differences in vertically transmitted foundational gut microbes and subsequent gut microbiome and immune development. Thus, the human gut microbiome appears to adhere to the tenets of primary succession, the process of species diversification in a pristine ecosystem, central to which is the tenet that founder (or pioneer) species, (i.e. those that first colonize), shape ecosystem conditions and thus the pace and trajectory of subsequent species accumulation. We thus hypothesize that in those children protected against allergy and asthma development, specific early-life gut microbiome strains, and more specifically, their metabolic products, promote immune tolerance which shapes subsequent immune and microbial development throughout childhood protecting against disease development.
P3 aims to build upon our previous studies and address this hypothesis using both banked samples from WHEALS for which 10-year allergic sensitization and asthma outcomes are known, and prospectively collected longitudinal samples in this P01 from mother-infant dyads in children with a High Risk for Allergic Asthma Phenotype (HiRAAP) or Low Risk for Allergic Asthma Phenotype (LoRAAP) at age 2 years. P3 proposes to identify early-life gut microbial derived metabolites that promote immune functions associated with protection against allergic asthma development in childhood, identify their microbial source, and develop and, based on these findings, test a novel microbial polybiotic for its capacity to shape immune function and protect against airway allergic sensitization in mice. This study will advance our knowledge of how gut microbial strains and their products program protective immunity against childhood allergic asthma development, and serve as a foundation for primary prevention of the disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
2P01AI089473-06
Application #
9631851
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2018-09-01
Budget End
2019-08-31
Support Year
6
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Henry Ford Health System
Department
Type
DUNS #
073134603
City
Detroit
State
MI
Country
United States
Zip Code
48202
Durack, Juliana; Boushey, Homer A; Huang, Yvonne J (2018) Incorporating the airway microbiome into asthma phenotyping: Moving toward personalized medicine for noneosinophilic asthma. J Allergy Clin Immunol 141:82-83
Wegienka, Ganesa; Sitarik, Alexandra; Bassirpour, Gillian et al. (2018) The associations between eczema and food and inhalant allergen-specific IgE vary between black and white children. J Allergy Clin Immunol Pract 6:292-294.e2
Sitarik, Alexandra Rene; Kasmikha, Nena Sabri; Kim, Haejin et al. (2018) Breast-feeding and delivery mode modify the association between maternal atopy and childhood allergic outcomes. J Allergy Clin Immunol 142:2002-2004.e2
Cassidy-Bushrow, A E; Burmeister, C; Havstad, S et al. (2018) Prenatal antimicrobial use and early-childhood body mass index. Int J Obes (Lond) 42:1-7
Sitarik, A R; Havstad, S; Levin, A M et al. (2018) Dog introduction alters the home dust microbiota. Indoor Air 28:539-547
Sitarik, Alexandra R; Bobbitt, Kevin R; Havstad, Suzanne L et al. (2017) Breast Milk Transforming Growth Factor ? Is Associated With Neonatal Gut Microbial Composition. J Pediatr Gastroenterol Nutr 65:e60-e67
Johnson, Christine C; Ownby, Dennis R (2017) The infant gut bacterial microbiota and risk of pediatric asthma and allergic diseases. Transl Res 179:60-70
Havstad, Suzanne; Sitarik, Alexandra R; Johnson, Christine Cole et al. (2017) Allergic sensitization in American children of Middle Eastern ethnicity at age 2. Ann Allergy Asthma Immunol 119:464-466
Fonseca, W; Lucey, K; Jang, S et al. (2017) Lactobacillus johnsonii supplementation attenuates respiratory viral infection via metabolic reprogramming and immune cell modulation. Mucosal Immunol 10:1569-1580
Cassidy-Bushrow, Andrea E; Sitarik, Alexandra R; Havstad, Suzanne et al. (2017) Burden of higher lead exposure in African-Americans starts in utero and persists into childhood. Environ Int 108:221-227

Showing the most recent 10 out of 49 publications